Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Institute for Stem Cell Biology and Regenerative Medicine · Stanford Medicine · +1 more institution
Abstract
Mobilization of the T-cell response against cancer has the potential to achieve long-lasting cures. However, it is not known how to harness antigen-presenting cells optimally to achieve an effective antitumor T-cell response. In this study, we show that anti-CD47 antibody-mediated phagocytosis of cancer by macrophages can initiate an antitumor T-cell immune response. Using the ovalbumin model antigen system, anti-CD47 antibody-mediated phagocytosis of cancer cells by macrophages resulted in increased priming of OT-I T cells [cluster of differentiation 8-positive (CD8(+))] but decreased priming of OT-II T cells (CD4(+)). The CD4(+) T-cell response was characterized by a reduction in forkhead box P3-positive…
Citation impact
- FWCI
- 13.39
- Percentile
- 100%
- References
- 34
Authors
11- DTDiane TsengCorresponding
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford University
- JVJens-Peter Volkmer
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford University
- SBStephen B. Willingham
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford University
- HCHumberto Contreras-Trujillo
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford University
- JWJohn W. Fathman
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford University
Topics & keywords
- Cytotoxic T cell
- Phagocytosis
- Immune system
- Priming (agriculture)
- CD47
- T cell
- Cancer cell
- Macrophage
- Good health and well-being